TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - MERCK & CO. Stock

Certificat

DE000SU993C7

Market Closed - Bid/Ask 15:35:58 2024-05-13 EDT After market 15:59:32
11.18 EUR +1.45% Intraday chart for TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - MERCK & CO. 11.14 -0.40%
Current month-0.71%
1 month-3.87%
Date Price Change Volume
24-05-13 11.18 +1.45% 0
24-05-10 11.02 -0.09% 0
24-05-09 11.03 -0.81% 0
24-05-08 11.12 +0.45% 0
24-05-07 11.07 -2.12% 0

Real-time Boerse Frankfurt Warrants

Last update May 13, 2024 at 03:35 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying MERCK & CO., INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SU993C
ISINDE000SU993C7
Date issued 2024-03-05
Strike 249 $
Maturity Unlimited
Parity 10 : 1
Emission price 11.42
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 11.85
Lowest since issue 10.74

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.1 USD
Average target price
141.6 USD
Spread / Average Target
+8.90%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW